Home > PJ > News / Daily News

Return to PJ Online Home Page

The Pharmaceutical Journal Vol 267 No 7162 p251-255
25 August 2001

This article
Reprint
Photocopy


News summary


Evidence on safety of infant soy formula

A new study provides reassuring evidence about the safety of infant soy formula. Compared with cow milk formula, exposure to soy formula in infancy does not appear to lead to different general health or reproductive outcomes, the authors say.

Dr Brian Strom, University of Pennsylvania School of Medicine, Philadelphia, and colleagues carried out a retrospective cohort study of 811 adults aged 20 to 34 years who had participated in controlled feeding studies as infants. During infancy, 248 were fed soy formula and 563 were fed cow milk formula.

The researchers say that infants fed soy formula receive relatively high levels of phytoestrogens, in the form of soy isoflavones, during a stage of development when permanent effects are theoretically possible. However, no significant differences were observed between those fed soy formula and those fed cow milk formula for either men or women with regard to adult height, usual weight, usual body mass index or any of the indexes of pubertal maturation.

They did find that women who had been fed soy formula reported slightly longer duration of menstrual bleeding and greater discomfort with menstruation. However, the clinical significance of these two findings is not known, they say.

The study is published in JAMA 2001; 286:807).

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal